| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
acknowledgements
|
|
|
|
20 |
S4 |
p. iv2-iv3
|
article
|
| 2 |
Acute myeloblastic leukemia in adult patients: ESMO Clinical Recommendations for diagnosis, treatment and follow-up
|
Fey, M.
|
|
|
20 |
S4 |
p. iv100-iv101
|
article
|
| 3 |
Advanced colorectal cancer: ESMO Clinical Recommendations for diagnosis, treatment and follow-up
|
Van Cutsem, E.
|
|
|
20 |
S4 |
p. iv61-iv63
|
article
|
| 4 |
Anal cancer: ESMO Clinical Recommendations for diagnosis, treatment and follow-up
|
Glynne-Jones, R.
|
|
|
20 |
S4 |
p. iv57-iv60
|
article
|
| 5 |
Biliary cancer: ESMO Clinical Recommendation for diagnosis, treatment and follow-up
|
Eckel, F.
|
|
|
20 |
S4 |
p. iv46-iv48
|
article
|
| 6 |
BRCA in breast cancer: ESMO Clinical Recommendations
|
Balmaña, J.
|
|
|
20 |
S4 |
p. iv19-iv20
|
article
|
| 7 |
Cancer, fertility and pregnancy: ESMO Clinical Recommendations for diagnosis, treatment and follow-up
|
Pentheroudakis, G.
|
|
|
20 |
S4 |
p. iv178-iv181
|
article
|
| 8 |
Cancers of unknown primary site: ESMO Clinical Recommendations for diagnosis, treatment and follow-up
|
Briasoulis, E.
|
|
|
20 |
S4 |
p. iv154-iv155
|
article
|
| 9 |
Cervical cancer: ESMO Clinical Recommendations for diagnosis, treatment and follow-up
|
Haie-Meder, C.
|
|
|
20 |
S4 |
p. iv27-iv28
|
article
|
| 10 |
Chemotherapy-induced nausea and vomiting: ESMO Clinical Recommendations for prophylaxis
|
Herrstedt, J.
|
|
|
20 |
S4 |
p. iv156-iv158
|
article
|
| 11 |
Chronic lymphocytic leukemia: ESMO Minimum Clinical Recommendations for diagnosis, treatment and follow-up
|
Eichhorst, B.
|
|
|
20 |
S4 |
p. iv102-iv104
|
article
|
| 12 |
Chronic myelogenous leukemia: ESMO Clinical Recommendations for diagnosis, treatment and follow-up
|
Baccarani, M.
|
|
|
20 |
S4 |
p. iv105-iv107
|
article
|
| 13 |
Cutaneous malignant melanoma: ESMO Clinical Recommendations for diagnosis, treatment and follow-up
|
Dummer, R.
|
|
|
20 |
S4 |
p. iv129-iv131
|
article
|
| 14 |
Differentiated thyroid cancer: ESMO Clinical Recommendations for diagnosis, treatment and follow-up
|
Pacini, F.
|
|
|
20 |
S4 |
p. iv143-iv146
|
article
|
| 15 |
Diffuse large B-cell non-Hodgkin's lymphoma: ESMO Clinical Recommendations for diagnosis, treatment and follow-up
|
Tilly, H.
|
|
|
20 |
S4 |
p. iv110-iv112
|
article
|
| 16 |
Editorial Board
|
|
|
|
20 |
S4 |
p. ii-iii
|
article
|
| 17 |
Endometrial carcinoma: ESMO Clinical Recommendations for diagnosis, treatment and follow-up
|
Baekelandt, M.M.
|
|
|
20 |
S4 |
p. iv29-iv31
|
article
|
| 18 |
Erythropoiesis-stimulating agents in cancer patients: ESMO Recommendations for use
|
Scrijvers, D.
|
|
|
20 |
S4 |
p. iv159-iv161
|
article
|
| 19 |
ESMO Clinical Recommendations: using the easier and faster approach to oncology guidelines
|
Pavlidis, N.
|
|
|
20 |
S4 |
p. iv7-iv9
|
article
|
| 20 |
ESMO Guidelines Working Group Disclosures
|
|
|
|
20 |
S4 |
p. iv185-iv186
|
article
|
| 21 |
Esophageal cancer: ESMO Clinical Recommendations for diagnosis, treatment and follow-up
|
Stahl, M.
|
|
|
20 |
S4 |
p. iv32-iv33
|
article
|
| 22 |
Ewing's sarcoma of the bone: ESMO Clinical Recommendations for diagnosis, treatment and follow-up
|
Paulussen, M.
|
|
|
20 |
S4 |
p. iv140-iv142
|
article
|
| 23 |
Familial colorectal cancer risk: ESMO Clinical Recommendations
|
Vasen, H.F.A.
|
|
|
20 |
S4 |
p. iv51-iv53
|
article
|
| 24 |
Gastric cancer: ESMO Clinical Recommendations for diagnosis, treatment and follow-up
|
Jackson, C.
|
|
|
20 |
S4 |
p. iv34-iv36
|
article
|
| 25 |
Gastric marginal zone lymphoma of MALT type: ESMO Clinical Recommendations for diagnosis, treatment and follow-up
|
Zucca, E.
|
|
|
20 |
S4 |
p. iv113-iv114
|
article
|
| 26 |
Gastrointestinal stromal tumours: ESMO Clinical Recommendations for diagnosis, treatment and follow-up
|
Casali, P.G.
|
|
|
20 |
S4 |
p. iv64-iv67
|
article
|
| 27 |
Guidelines Working Group Members
|
|
|
|
20 |
S4 |
p. iv1
|
article
|
| 28 |
Hematopoietic growth factors: ESMO Recommendations for the applications
|
Crawford, J.
|
|
|
20 |
S4 |
p. iv162-iv165
|
article
|
| 29 |
Hepatocellular carcinoma: ESMO Clinical Recommendations for diagnosis, treatment and follow-up
|
Jelic, S.
|
|
|
20 |
S4 |
p. iv41-iv45
|
article
|
| 30 |
Hodgkin's lymphoma: ESMO Clinical Recommendations for diagnosis, treatment and follow-up
|
Engert, A.
|
|
|
20 |
S4 |
p. iv108-iv109
|
article
|
| 31 |
Invasive bladder cancer: ESMO Clinical Recommendations for diagnosis, treatment and follow-up
|
Bellmunt, J.
|
|
|
20 |
S4 |
p. iv79-iv80
|
article
|
| 32 |
Locally recurrent or metastatic breast cancer: ESMO Clinical Recommendations for diagnosis, treatment and follow-up
|
Cardoso, F.
|
|
|
20 |
S4 |
p. iv15-iv18
|
article
|
| 33 |
Malignant glioma: ESMO Clinical Recommendations for diagnosis, treatment and follow-up
|
Stupp, R.
|
|
|
20 |
S4 |
p. iv126-iv128
|
article
|
| 34 |
Malignant pleural mesothelioma: ESMO Clinical Recommendations for diagnosis, treatment and follow-up
|
Stahel, R.A.
|
|
|
20 |
S4 |
p. iv73-iv75
|
article
|
| 35 |
Management of cancer pain: ESMO Clinical Recommendations
|
Jost, L.
|
|
|
20 |
S4 |
p. iv170-iv173
|
article
|
| 36 |
Management of febrile neutropenia: ESMO Clinical Recommendations
|
Marti Marti, F.
|
|
|
20 |
S4 |
p. iv166-iv169
|
article
|
| 37 |
Management of oral and gastrointestinal mucositis: ESMO Clinical Recommendations
|
Peterson, D.E.
|
|
|
20 |
S4 |
p. iv174-iv177
|
article
|
| 38 |
Management of venous thromboembolism in cancer patients: ESMO Clinical Recommendations
|
Mandalà, M.
|
|
|
20 |
S4 |
p. iv182-iv184
|
article
|
| 39 |
Multiple myeloma: ESMO Clinical Recommendations for diagnosis, treatment and follow-up
|
Harousseau, J.-L.
|
|
|
20 |
S4 |
p. iv97-iv99
|
article
|
| 40 |
Nasopharyngeal cancer: ESMO Clinical Recommendations for diagnosis, treatment and follow-up
|
Chan, A.T.C.
|
|
|
20 |
S4 |
p. iv123-iv125
|
article
|
| 41 |
Neuroendocrine bronchial and thymic tumors: ESMO Clinical Recommendation for diagnosis, treatment and follow-up
|
Oberg, K.
|
|
|
20 |
S4 |
p. iv147-iv149
|
article
|
| 42 |
Neuroendocrine gastroenteropancreatic tumors: ESMO Clinical Recommendation for diagnosis, treatment and follow-up
|
Oberg, K.
|
|
|
20 |
S4 |
p. iv150-iv153
|
article
|
| 43 |
Newly and relapsed epithelial ovarian carcinoma: ESMO Clinical Recommendations for diagnosis, treatment and follow-up
|
Aebi, S.
|
|
|
20 |
S4 |
p. iv21-iv23
|
article
|
| 44 |
Newly diagnosed and relapsed follicular lymphoma: ESMO Clinical Recommendations for diagnosis, treatment and follow-up
|
Dreyling, M.
|
|
|
20 |
S4 |
p. iv119-iv120
|
article
|
| 45 |
Non-epithelial ovarian cancer: ESMO Clinical Recommendations for diagnosis, treatment and follow-up
|
Colombo, N.
|
|
|
20 |
S4 |
p. iv24-iv26
|
article
|
| 46 |
Non-small-cell lung cancer: ESMO Clinical Recommendations for diagnosis, treatment and follow-up
|
D'Addario, G.
|
|
|
20 |
S4 |
p. iv68-iv70
|
article
|
| 47 |
Osteosarcoma: ESMO Clinical Recommendations for diagnosis, treatment and follow-up
|
Bielack, S.
|
|
|
20 |
S4 |
p. iv137-iv139
|
article
|
| 48 |
Pancreatic cancer: ESMO Clinical Recommendations for diagnosis, treatment and follow-up
|
Cascinu, S.
|
|
|
20 |
S4 |
p. iv37-iv40
|
article
|
| 49 |
Primary breast cancer: ESMO Clinical Recommendations for diagnosis, treatment and follow-up
|
Kataja, V.
|
|
|
20 |
S4 |
p. iv10-iv14
|
article
|
| 50 |
Primary colon cancer: ESMO Clinical Recommendations for diagnosis, adjuvant treatment and follow-up
|
Van Cutsem, E.
|
|
|
20 |
S4 |
p. iv49-iv50
|
article
|
| 51 |
Primary cutaneous lymphoma: ESMO Clinical Recommendations for diagnosis, treatment and follow-up
|
Willemze, R.
|
|
|
20 |
S4 |
p. iv115-iv118
|
article
|
| 52 |
Prostate cancer: ESMO Clinical Recommendations for diagnosis, treatment and follow-up
|
Horwich, A.
|
|
|
20 |
S4 |
p. iv76-iv78
|
article
|
| 53 |
Rectal cancer: ESMO Clinical Recommendations for diagnosis, treatment and follow-up
|
Glimelius, B.
|
|
|
20 |
S4 |
p. iv54-iv56
|
article
|
| 54 |
Renal cell carcinoma: ESMO Clinical Recommendations for diagnosis, treatment and follow-up
|
Escudier, B.
|
|
|
20 |
S4 |
p. iv81-iv82
|
article
|
| 55 |
Small-cell lung cancer: ESMO Clinical Recommendations for diagnosis, treatment and follow-up
|
Sørensen, M.
|
|
|
20 |
S4 |
p. iv71-iv72
|
article
|
| 56 |
Soft tissue sarcomas: ESMO Clinical Recommendations for diagnosis, treatment and follow-up
|
Casali, P.G.
|
|
|
20 |
S4 |
p. iv132-iv136
|
article
|
| 57 |
Squamous cell carcinoma of the head and neck: ESMO Clinical Recommendations for diagnosis, treatment and follow-up
|
Licitra, L.
|
|
|
20 |
S4 |
p. iv121-iv122
|
article
|
| 58 |
Table of Contents
|
|
|
|
20 |
S4 |
p. v
|
article
|
| 59 |
Testicular non-seminoma: ESMO Clinical Recommendations for diagnosis, treatment and follow-up
|
Schmoll, H.-J.
|
|
|
20 |
S4 |
p. iv89-iv96
|
article
|
| 60 |
Testicular seminoma: ESMO Clinical Recommendations for diagnosis, treatment and follow-up
|
Schmoll, H.-J.
|
|
|
20 |
S4 |
p. iv83-iv88
|
article
|
| 61 |
Title Page
|
|
|
|
20 |
S4 |
p. iv
|
article
|
Journal description